|Sponsor||Rep. Young, C. W. Bill|
|Date||September 28, 2010 (111th Congress, 2nd Session)|
|Staff Contact||Brian McManus|
H.R. 6081 is expected to be considered on the House floor on Wednesday, September 29, 2010, under a suspension of the rules, requiring a two-thirds majority vote to pass. Rep. C.W. Bill Young (R-FL) introduced H.R. 6081 on August 9, 2010, and it was referred to the Committee on Energy and Commerce.
H.R. 6081 would reauthorize the C.W. Bill Young Cell Transplantation Program, which includes the National Registry for adult donors of bone marrow, peripheral blood [adult] stem cells, and umbilical cord blood units, as well as the National Cord Blood Inventory (NCBI) for an additional 5 year period. The current authorization expires at the end of Fiscal Year 2010.
Specifically, H.R. 6081 would do the following:
In 2005, Congress approved the Stem Cell Therapeutic and Research Act of 2005, which facilitated the use of umbilical-cord-blood stem cells in biomedical research and in the treatment of disease. Cord-blood stem cells, collected from the placenta and umbilical cord after birth without doing harm to mother or child, have been used in the treatment of thousands of patients suffering from more than 60 different diseases, including leukemia, Fanconi anemia, sickle cell disease, and thalassemia. Researchers also believe cord-blood stem cells may have the capacity to be differentiated into other cell types, making them useful in the exploration of ethical stem cell therapies for regenerative medicine.
As of publication, the Congressional Budget Office had not released a score of H.R. 6081.